Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial
Jing Kang, Sijia Li, Jinglin Su, Zhixue Xiao, Siyi Zhang, Shuangxin Liu, Pingjiang Ge · 2024
Read Effect of sodium zirconium cyclosilicate on hyperkalemia after parathyroidectomy in secondary hyperparathyroidism patients with maintenance hemodialysis: A randomized trial by Jing Kang, Sijia Li, Jinglin Su, Zhixue Xiao, Siyi Zhang, Shuangxin Liu, Pingjiang Ge (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11688067.txt.
Description
Jing Kang and co-authors run a randomized trial of a potassium-lowering drug around parathyroid surgery, in a 2024 study. Patients on long-term dialysis with overactive parathyroid glands often face dangerous potassium spikes after surgery. The drug tested, sodium zirconium cyclosilicate, binds potassium in the gut. Patients took it just before their operation in the treatment group.
Blood tests were taken before and after surgery in both groups. The hormone targeted by surgery fell sharply in everyone. Potassium levels matched early on, but by that evening the treated group ran clearly lower. Three control patients needed emergency treatment for severe potassium highs. No treated patient needed such rescue care.
Catalog record
| CREATOR | Jing Kang, Sijia Li, Jinglin Su, Zhixue Xiao, Siyi Zhang, Shuangxin Liu, Pingjiang Ge |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |